Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 4:30 PM View:  | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 18-Nov-24 | Option Sale | 2,602 | $13.21 | $34,372.90 | (1%) 242.74K to 240.13K | |
| 19-Nov-24 4:32 PM View: | Dubow Adam General Counsel | Day One Biopharmaceuticals,... (DAWN) | 18-Nov-24 | Option Sale | 3,165 | $13.21 | $41,810.30 | (9%) 35.33K to 32.16K | |
| 19-Nov-24 4:34 PM View: | Blackman Samuel C. HEAD OF R&D | Day One Biopharmaceuticals,... (DAWN) | 18-Nov-24 | Option Sale | 2,206 | $13.21 | $29,141.70 | (< 1%) 2.07M to 2.06M | |
| 19-Nov-24 4:36 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 18-Nov-24 | Option Sale | 10,554 | $13.21 | $139,420.00 | (< 1%) 1.73M to 1.72M | |
| 19-Nov-24 4:34 PM View: | Blackman Samuel C. HEAD OF R&D | Day One Biopharmaceuticals,... (DAWN) | 15-Nov-24 | Option Exercise | 8,686 | -- | -- | < 1% 2.06M to 2.07M | |
| 19-Nov-24 4:36 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 15-Nov-24 | Option Exercise | 19,999 | -- | -- | 1% 1.71M to 1.73M | |
| 19-Nov-24 4:30 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 15-Nov-24 | Option Exercise | 10,250 | -- | -- | 4% 232.49K to 242.74K | |
| 19-Nov-24 4:32 PM View: | Dubow Adam General Counsel | Day One Biopharmaceuticals,... (DAWN) | 15-Nov-24 | Option Exercise | 8,399 | -- | -- | 31% 26.93K to 35.33K | |
| 12-Sep-24 4:48 PM View: | Blackman Samuel C. HEAD OF R&D | Day One Biopharmaceuticals,... (DAWN) | 10-Sep-24 | Market Sale (Planned) | 30,000 | $14.22 | $426,675.00 | (1%) 2.13M to 2.1M | (2%) |
| 17-Jul-24 4:53 PM View: | Blackman Samuel C. HEAD OF R&D | Day One Biopharmaceuticals,... (DAWN) | 16-Jul-24 | Market Sale (Planned) | 20,000 | $16.01 | $320,226.00 | (< 1%) 2.14M to 2.12M | 10% |
| 05-Jul-24 6:11 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 02-Jul-24 | Gift | 241,912 | -- | -- | (12%) 1.94M to 1.7M | |
| 05-Jul-24 6:11 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 02-Jul-24 | Gift | 241,912 | -- | -- | 14% 1.7M to 1.94M | |
| 21-Jun-24 7:17 PM View: | Ramasastry Saira Director | Day One Biopharmaceuticals,... (DAWN) | 21-Jun-24 | Market Sale | 10,000 | $13.19 | $131,877.00 | (20%) 50.48K to 40.48K | (10%) |
| 12-Jun-24 4:29 PM View: | Blackman Samuel C. HEAD OF R&D | Day One Biopharmaceuticals,... (DAWN) | 10-Jun-24 | Market Sale (Planned) | 30,000 | $12.62 | $378,588.00 | (1%) 2.17M to 2.14M | (15%) |
| 17-May-24 6:27 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 16-May-24 | Option Sale | 7,873 | $16.08 | $126,588.00 | (< 1%) 1.71M to 1.7M | |
| 17-May-24 6:15 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 16-May-24 | Option Sale | 2,675 | $16.08 | $43,010.50 | (1%) 227.54K to 224.87K | |
| 17-May-24 6:11 PM View: | Dubow Adam General Counsel | Day One Biopharmaceuticals,... (DAWN) | 16-May-24 | Option Sale | 3,253 | $16.08 | $52,304.00 | (13%) 24.98K to 21.73K | |
| 17-May-24 6:18 PM View: | Blackman Samuel C. HEAD OF R&D | Day One Biopharmaceuticals,... (DAWN) | 16-May-24 | Option Sale | 2,267 | $16.08 | $36,450.40 | (< 1%) 2.17M to 2.17M | |
| 17-May-24 6:18 PM View: | Blackman Samuel C. HEAD OF R&D | Day One Biopharmaceuticals,... (DAWN) | 15-May-24 | Option Exercise | 8,686 | -- | -- | < 1% 2.16M to 2.17M | |
| 17-May-24 6:27 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 15-May-24 | Option Exercise | 19,999 | -- | -- | 1% 1.69M to 1.71M | |
| 17-May-24 6:15 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 15-May-24 | Option Exercise | 10,250 | -- | -- | 5% 217.29K to 227.54K | |
| 17-May-24 6:11 PM View: | Dubow Adam General Counsel | Day One Biopharmaceuticals,... (DAWN) | 15-May-24 | Option Exercise | 8,399 | -- | -- | 51% 16.59K to 24.98K | |
| 14-May-24 6:13 PM View: | Blackman Samuel C. HEAD OF R&D | Day One Biopharmaceuticals,... (DAWN) | 10-May-24 | Market Sale (Planned) | 10,000 | $16.37 | $163,743.00 | (< 1%) 2.17M to 2.16M | 12% |
| 03-May-24 6:48 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 03-May-24 | Sale (Planned) | 9,154 | $17.85 | $163,417.00 | (< 1%) 1.7M to 1.69M | |
| 03-May-24 6:44 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 03-May-24 | Sale (Planned) | 8,078 | $17.85 | $144,214.00 | (4%) 225.37K to 217.29K | |
| 03-May-24 6:48 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 02-May-24 | Sale (Planned) | 6 | $17.94 | $107.62 | (< 1%) 1.7M to 1.7M | |
| 03-May-24 6:44 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 02-May-24 | Sale (Planned) | 200 | $17.90 | $3,579.10 | (< 1%) 225.57K to 225.37K | |
| 03-May-24 6:48 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 01-May-24 | Private Sale (Planned) | 70,051 | $17.88 | $1,252,180.00 | (4%) 1.77M to 1.7M | |
| 03-May-24 6:44 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 01-May-24 | Private Sale (Planned) | 52,183 | $17.89 | $933,397.00 | (19%) 277.75K to 225.57K | |
| 22-Apr-24 6:36 PM View: | Blackman Samuel C. HEAD OF R&D | Day One Biopharmaceuticals,... (DAWN) | 18-Apr-24 | Market Sale (Planned) | 10,000 | $16.02 | $160,163.00 | (< 1%) 2.18M to 2.17M | 10% |
| 26-Mar-24 6:09 PM View: | Blackman Samuel C. HEAD OF R&D | Day One Biopharmaceuticals,... (DAWN) | 25-Mar-24 | Market Sale (Planned) | 10,000 | $16.01 | $160,055.00 | (< 1%) 2.19M to 2.18M | 10% |
| 13-Mar-24 4:24 PM View: | Blackman Samuel C. HEAD OF R&D | Day One Biopharmaceuticals,... (DAWN) | 11-Mar-24 | Market Sale (Planned) | 30,000 | $15.24 | $457,314.00 | (1%) 2.22M to 2.19M | 5% |
| 28-Feb-24 7:55 PM View: | Blackman Samuel C. HEAD OF R&D | Day One Biopharmaceuticals,... (DAWN) | 27-Feb-24 | Market Sale (Planned) | 20,000 | $16.11 | $322,166.00 | (< 1%) 2.24M to 2.22M | 10% |
| 20-Feb-24 6:14 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 16-Feb-24 | Option Sale | 7,615 | $15.25 | $116,114.00 | (< 1%) 1.77M to 1.77M | |
| 20-Feb-24 6:36 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 16-Feb-24 | Option Sale | 2,666 | $15.25 | $40,651.40 | (< 1%) 280.42K to 277.75K | |
| 20-Feb-24 6:48 PM View: | Dubow Adam General Counsel | Day One Biopharmaceuticals,... (DAWN) | 16-Feb-24 | Option Sale | 3,242 | $15.25 | $49,434.30 | (16%) 19.83K to 16.59K | |
| 20-Feb-24 6:26 PM View: | Blackman Samuel C. Head of Research and Developme | Day One Biopharmaceuticals,... (DAWN) | 16-Feb-24 | Option Sale | 2,258 | $15.25 | $34,430.20 | (< 1%) 2.25M to 2.24M | |
| 20-Feb-24 6:26 PM View: | Blackman Samuel C. Head of Research and Developme | Day One Biopharmaceuticals,... (DAWN) | 15-Feb-24 | Option Exercise | 8,686 | -- | -- | < 1% 2.24M to 2.25M | |
| 20-Feb-24 6:14 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 15-Feb-24 | Option Exercise | 19,999 | -- | -- | 1% 1.75M to 1.77M | |
| 20-Feb-24 6:36 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 15-Feb-24 | Option Exercise | 10,250 | -- | -- | 4% 270.17K to 280.42K | |
| 20-Feb-24 6:48 PM View: | Dubow Adam General Counsel | Day One Biopharmaceuticals,... (DAWN) | 15-Feb-24 | Option Exercise | 8,399 | -- | -- | 73% 11.43K to 19.83K | |
| 17-Nov-23 6:33 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 16-Nov-23 | Option Sale | 956 | $11.69 | $11,175.60 | (< 1%) 271.13K to 270.17K | |
| 17-Nov-23 6:30 PM View: | Dubow Adam General Counsel | Day One Biopharmaceuticals,... (DAWN) | 16-Nov-23 | Option Sale | 5,313 | $11.69 | $62,109.00 | (32%) 16.74K to 11.43K | |
| 17-Nov-23 6:26 PM View: | Blackman Samuel C. Head of Research and Developme | Day One Biopharmaceuticals,... (DAWN) | 16-Nov-23 | Option Sale | 709 | $11.69 | $8,288.21 | (< 1%) 2.24M to 2.24M | |
| 17-Nov-23 6:20 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 16-Nov-23 | Option Sale | 3,107 | $11.69 | $36,320.80 | (< 1%) 1.76M to 1.75M | |
| 17-Nov-23 6:26 PM View: | Blackman Samuel C. Head of Research and Developme | Day One Biopharmaceuticals,... (DAWN) | 15-Nov-23 | Option Exercise | 2,624 | -- | -- | < 1% 2.24M to 2.24M | |
| 17-Nov-23 6:20 PM View: | Bender Jeremy Chief Executive Officer Director | Day One Biopharmaceuticals,... (DAWN) | 15-Nov-23 | Option Exercise | 8,312 | -- | -- | < 1% 1.75M to 1.76M | |
| 17-Nov-23 6:33 PM View: | York Charles N II COO, CFO and Secretary | Day One Biopharmaceuticals,... (DAWN) | 15-Nov-23 | Option Exercise | 3,625 | -- | -- | 1% 267.5K to 271.13K | |
| 17-Nov-23 6:30 PM View: | Dubow Adam General Counsel | Day One Biopharmaceuticals,... (DAWN) | 15-Nov-23 | Option Exercise | 13,600 | -- | -- | 433% 3.14K to 16.74K | |
| 20-Oct-23 4:02 PM View: | Ai Day 1 LLC 10% Owner | Day One Biopharmaceuticals,... (DAWN) | 20-Oct-23 | Purchase | 111,387 | $9.97 | $1,110,910.00 | < 1% 12.82M to 12.93M |
